Raffa Wealth Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
Raffa Wealth Management's PTCT Position: Q3 2026 in Review
Raffa Wealth Management held its PTC Therapeutics (PTCT) position steady in Q3 2026 at 11 shares worth $713. The position accounts for ﹤0.01% of the portfolio, ranked #1107.
Raffa Wealth Management first reported a position in PTCT in Q1 2020 and has held it in 27 quarters since. The position peaked at $900 in Q1 2021. 358 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.
- Raffa Wealth Management held 11 shares of PTC Therapeutics worth $713 as of Q3 2026.
- Raffa Wealth Management left its PTC Therapeutics share count unchanged in Q3 2026.
- PTC Therapeutics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1107 holding.
- Raffa Wealth Management first reported a position in PTC Therapeutics in Q1 2020 and has held it in 27 quarters since.
- Raffa Wealth Management's PTC Therapeutics position peaked at $900 in Q1 2021.
- 358 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.